Royal London Asset Management Ltd. Trims Stock Position in STERIS plc (NYSE:STE)

Royal London Asset Management Ltd. decreased its holdings in STERIS plc (NYSE:STE - Free Report) by 20.2% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 560,902 shares of the medical equipment provider's stock after selling 141,996 shares during the period. Royal London Asset Management Ltd. owned about 0.57% of STERIS worth $115,299,000 as of its most recent filing with the Securities & Exchange Commission.

Other large investors have also recently made changes to their positions in the company. Avalon Trust Co purchased a new stake in shares of STERIS in the 4th quarter worth $30,000. Human Investing LLC purchased a new stake in STERIS in the fourth quarter worth about $31,000. Anfield Capital Management LLC grew its holdings in STERIS by 100.0% during the 4th quarter. Anfield Capital Management LLC now owns 182 shares of the medical equipment provider's stock worth $37,000 after acquiring an additional 91 shares in the last quarter. Central Pacific Bank Trust Division increased its position in STERIS by 65.5% during the 4th quarter. Central Pacific Bank Trust Division now owns 192 shares of the medical equipment provider's stock valued at $39,000 after purchasing an additional 76 shares during the period. Finally, Manchester Capital Management LLC raised its holdings in shares of STERIS by 182.7% in the 4th quarter. Manchester Capital Management LLC now owns 212 shares of the medical equipment provider's stock valued at $44,000 after purchasing an additional 137 shares in the last quarter. 94.69% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

STE has been the topic of a number of analyst reports. Piper Sandler lifted their price target on STERIS from $260.00 to $265.00 and gave the company an "overweight" rating in a report on Monday, February 3rd. JMP Securities reiterated a "market outperform" rating and issued a $265.00 target price on shares of STERIS in a report on Thursday, February 6th. Finally, Stephens restated an "overweight" rating and issued a $240.00 price target on shares of STERIS in a report on Thursday, February 6th. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $258.75.

Remove Ads

STERIS Stock Up 1.2 %

Shares of STE stock traded up $2.61 during trading hours on Monday, reaching $223.03. 439,743 shares of the company's stock were exchanged, compared to its average volume of 504,161. The stock has a market cap of $21.91 billion, a PE ratio of 47.35 and a beta of 0.92. The company has a current ratio of 2.13, a quick ratio of 1.40 and a debt-to-equity ratio of 0.32. The stock's fifty day moving average price is $221.02 and its two-hundred day moving average price is $221.84. STERIS plc has a 1 year low of $197.82 and a 1 year high of $248.24.

STERIS (NYSE:STE - Get Free Report) last issued its quarterly earnings results on Wednesday, February 5th. The medical equipment provider reported $2.32 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.33 by ($0.01). STERIS had a net margin of 8.66% and a return on equity of 13.91%. Research analysts predict that STERIS plc will post 9.08 EPS for the current year.

STERIS Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 21st. Stockholders of record on Thursday, February 20th were issued a $0.57 dividend. This represents a $2.28 dividend on an annualized basis and a dividend yield of 1.02%. The ex-dividend date of this dividend was Thursday, February 20th. STERIS's dividend payout ratio is presently 48.41%.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.